Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Viemed Healthcare Inc VMD

Viemed Healthcare, Inc. through its subsidiaries, is a provider of home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The Company’s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counselling to patients in their homes using cutting edge technologies. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, and other medical equipment. In-home sleep testing provides in home sleep apnea testing services. Healthcare staffing provides healthcare staffing and recruitment services. The Company provides home medical equipment services through its interest in East Alabama HomeMed, LLC (HomeMed).


NDAQ:VMD - Post by User

Post by donmayneon Feb 13, 2022 8:27am
215 Views
Post# 34424064

PROMOTING ACCEPTANCE AND ADHERENCE TO NIV in COPD

PROMOTING ACCEPTANCE AND ADHERENCE TO NIV in COPD

VMD began hiring social workers.  It appears leading edge in terms of improving adherence and quality of life.  

PROMOTING ACCEPTANCE AND ADHERENCE TO NON-INVASIVE VENTILATION IN COPD. A RANDOMIZED CONTROLLED TRIAL

ABSTRACT

OBJECTIVE: People with Chronic Obstructive Pulmonary Disease (COPD) may suffer from anxiety, depression, low quality of life, and cognitive deficits that could play a role in their clinical conditions. These situations could be worsened during the adaptation process to a new treatment such as non-invasive ventilation (NIV), which is often rejected or inappropriately used. The study aimed to analyse the impact of a brief psychological support intervention on adherence to NIV among patients with COPD.

METHODS: A two-branch randomized controlled trial was conducted with 90 patients with COPD who had an indication for NIV. The experimental group received cognitive behavioural therapy (CBT) support, including counselling, relaxation and mindfulness-based exercises. Controls received standard care and watched educational videos. The course had been structured over 4 to 8 meetings at the hospital, at home and/or via telemedicine.

RESULTS: The psychological intervention was related to improvements in both adherence to NIV (F(304) = 19.054, p < .001) and quality of life (F(156) = 10.264, p = .002) after 8 meetings from baseline compared to the control group. Results indicated a significant change in the quality of life also over time (F(71.480) = 8.114, p = .006).
CONCLUSIONS: The findings suggest that the psychological intervention is an appropriate treatment for acceptance of and adherence to NIV in COPD in clinical practice and highlight the importance of determining the underlying reasons for NIV use.Trial registration:ClinicalTrials.govidentifier NCT02499653.

<< Previous
Bullboard Posts
Next >>